Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly

Written on 05/11/2024

In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson explained how his company uses new AI technology to develop drugs.
Read full article